Targeting a 10% reduction in energy and water consumption, and a 30% cut in carbon emissions across facilities by 2025
Breakthrough UNITY 4D Phaco delivers up to 2X faster nucleus removal and 41% less energy into the eye
Vonvendi is the only recombinant Von Willebrand factor replacement therapy with approved indications in adults and children with VWD
Now integrates with Abbott’s instinct sensor and approved for type 2 diabetes
The trial is the largest to date evaluating Leqvio and the first to focus on patient-centered outcomes
Treatment with Verzenio also resulted in sustained invasive disease-free survival and distant relapse-free survival benefit
New manufacturing facility in Mebane to produce at least 40 million laboratory pipette tips per week
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
The Q-Switched Nd:YAG system is suitable for all skin types and offers versatility in treating dermal and epidermal pigmentation
Subscribe To Our Newsletter & Stay Updated
